Conversely, cells from CML patients expressing undetectable levels of PTPRG displayed the highest levels of Y245-phospho-BCR-ABL1 and Y654-phospho-β-catenin. This evidence concerns the gene PTPRG and chronic myelogenous leukemia, BCR-ABL1 positive.